Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
<h4>Background</h4>There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs) to angiotensin-converting enzyme (ACE) inhibitors outweighs the increased risk of adverse effects in patients with heart failure.<h4>Methodology/principal finding...
Guardado en:
Autores principales: | Andrea Kuenzli, Heiner C Bucher, Inder Anand, Gregory Arutiunov, Leo C Kum, Robert McKelvie, Rizwan Afzal, Michel White, Alain J Nordmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8193889c7c6b4f7c9048f7ccd85da341 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021) -
ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Ahmed Daoud, et al.
Publicado: (2021) -
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
por: Miklós Fagyas, et al.
Publicado: (2014) -
Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
por: Ya-Feng Li, et al.
Publicado: (2012) -
New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
por: Miklós Fagyas, et al.
Publicado: (2014)